Prescription Cough Medicines That Do Not Increase Blood Pressure

Introduction to Cough Suppression

The American College of Physicians recommends benzonatate as a peripherally-acting antitussive that anesthetizes stretch receptors in the respiratory passages without any cardiovascular effects, making it ideal for patients with hypertension or blood pressure concerns 1, 2
Prescription-strength dextromethorphan is recommended as the first-line antitussive due to its superior safety profile and lack of cardiovascular effects, though standard over-the-counter dosing is often subtherapeutic 1, 2

Maximum cough reflex suppression occurs at 60 mg of dextromethorphan, which is higher than typical OTC preparations 1, 2
Standard prescription dosing of dextromethorphan is 10-15 mg three to four times daily, with a maximum daily dose of 120 mg 2
For severe cough, a single 60 mg dose of dextromethorphan can provide prolonged suppression 1, 2

The American Heart Association recommends avoiding decongestant-containing preparations, such as pseudoephedrine or phenylephrine, which can elevate blood pressure and should be avoided in patients with uncontrolled hypertension 3
Codeine and hydrocodone are not recommended as they offer no efficacy advantage over dextromethorphan but have significantly greater adverse effects, and lack robust evidence in modern trials 1, 2, 4

The American College of Cardiology recommends assessing patient cardiovascular status and avoiding all decongestant-containing preparations if hypertension or cardiovascular disease is present 3
Prescription-strength dextromethorphan at therapeutic doses (30-60 mg) is an alternative to benzonatate 1, 2

The American Academy of Pediatrics recommends simple home remedies like honey and lemon, which may be as effective as pharmacological treatments for benign viral cough 1, 2
Menthol inhalation provides acute but short-lived suppression without cardiovascular effects 1, 2

The National Institute of Health recommends avoiding prescribing combination cough/cold products without checking for decongestant content, as many contain pseudoephedrine or phenylephrine that elevate blood pressure 3
Using subtherapeutic doses of dextromethorphan, as standard OTC dosing (15-30 mg) is often insufficient, and therapeutic doses are 30-60 mg 1, 2
Defaulting to codeine-based products, which have no efficacy advantage over dextromethorphan but significantly more adverse effects 1, 2, 4
Continuing antitussive therapy beyond 3 weeks, as cough persisting beyond this timeframe requires diagnostic workup rather than continued suppression 2